Cardiology Letters, 2024 (roč. 33), číslo 6

Editoriál

Komentár k Odporúčaniam Európskej kardiologickej spoločnosti pre manažment endokarditídy 2023

Marek Orban, Martin Chudý, Marcela Tavačová

Cardiology Letters 2024, 33(6):353-358

Prehľadový článok

Left ventricular global longitudinal strain in the evaluation of left ventricular heart failure and ischaemic heart disease in modern echocardiography

Yashar Jalali, Jan Stevlik, Gabriel Kamensky, Monika Jalali, Juraj Payer

Cardiology Letters 2024, 33(6):359-370

Since its introduction into echocardiology around 20 years ago, speckle tracking (ST) has developed significantly, finding its place in daily clinical practice. Many applications have been tested and proposed for different modalities of ST. Longitudinal strain (LS) and, specifically, global longitudinal strain (GLS) have become the most utilised and studied modalities of ST. Due to their diagnostic/treatment complexities, heart failure (HF) and ischaemic heart disease (IHD) have become an important domain for the development of GLS. In recent years, many clinical studies, meta-analyses, and systematic reviews have tried to define the clinical applications...

Agonisty receptora glucagon like peptide 1: nová farmakologická liečba chronického srdcového zlyhávania so zachovanou ejekčnou frakciou ľavej komory

Norbert Nagy, Martin Jozef Péč, Jakub Jurica, Zuzana Miertová, Boris Focko, Tomáš Bolek, Matej Samoš, Marián Mokáň

Cardiology Letters 2024, 33(6):371-377

Úvod: Srdcové zlyhanie so zachovanou ejekčnou frakciou (HFpEF) je klinická podskupina definovaná náročnou diagnostikou, rôznorodými fenotypmi a komplexnou liečbou. HFpEF tvorí viac ako polovicu všetkých hospitalizácií v dôsledku dekompenzovaného srdcového zlyhania. Súčasné odporúčania na liečbu HFpEF odporúčajú použitie inhibítorov SGLT2 (sodíkového glukózového kotransportéra 2). HFpEF sa však často spája s obezitou a príchod nových liekov na liečbu obezity otvára ďalšie možnosti liečby. Metódy: V databázach PubMed, Web of Science, Scopus a Google Scholar sme vyhľadávali literatúru o pacientoch s HFpEF a jeho terapii. Analýza sa zamerala na nové lieky,...

Kazuistika

Rare case presentation of thoracic aortic aneurysm and aortic dissection in adolescent

Lucia Bobik, Peter Tittel, Marek Kardos, Erika Drangova, Michal Hulman, Vladimir Sojak, Fadi Sabateen, Kristina Kasicova, Peter Olejnik, Martin Zahorec, Gabriela Hrckova, Olivia Hamidova

Cardiology Letters 2024, 33(6):378-383

Introduction: Familial thoracic aortic aneurysm and aortic dissection (f/TAAD) is a genetic disease defined by disturbance in encoding the major proteins in the smooth muscle cells (SMC) contractile filaments of alpha-actin ACTA2 and myosin heavy chain MYH11, in an autosomal dominant pattern. MYH11 gene mutation is a rare cause of f/TAAD and is identified primarily in families with non-syndromic TAAD, inherited in association with patents ductus arteriosus (PDA). Case report: We present a 17-year-old girl with TAAD of ascending aorta and MYH11 gene mutation, confirmed respectively. At the first year of age, the patient underwent PDA interventional...